analyst-ratings

Ignite It
2 min read • December 6, 2019

Bank Of America Looks At Colorado Sales In Monthly Cannabis Tracker

Ignite It
2 min read • December 5, 2019

Canopy Growth Is Prepared For ‘Cannabis 2.0’ In Canada, Analysts Say

Ignite It
1 min read • December 3, 2019

Needham Initiates Coverage On Trulieve Cannabis with Buy Rating, Announces $20 Price Target

Ignite It
1 min read • December 2, 2019

Compass Point Upgrades Trulieve Cannabis to Buy, Raises Price Target to $17

Ignite It
3 min read • November 26, 2019

Brace For Stricter FDA Regulation Of CBD Consumer Products, Analysts Say

Ignite It
2 min read • November 26, 2019

Aurora Cannabis Analyst Says Company Poised To Outperform Canadian Peers

Ignite It
1 min read • November 25, 2019

420 Investor Alan Brochstein, When Asked About Weakness In Aurora Cannabis, Tells Benzinga ‘Holders were able to buy it at a discount and some are likely converting it’ Following Co.’s Early Amended Conversion Privilege For Convertible Debentures

Ignite It
1 min read • November 21, 2019

Stifel Says Removing Cannabis From Controlled Substances Act Would Be A Negative For US Cannabis Companies As It Would ‘Destroy Value Built Through The Limited Licenses Issued Under The Current State By State Regulation’

Ignite It
2 min read • November 21, 2019

Cannabis Short Sellers Down $272M Following Canopy Growth Upgrade

Ignite It
3 min read • November 20, 2019

European Cannabis Market Snapshot: An Analyst’s Highlights From The MedCann World Forum

Ignite It
1 min read • November 15, 2019

MKM Partners Maintains Sell on Aurora Cannabis, Lowers Price Target to $3

Ignite It
1 min read • November 15, 2019

Cantor Fitzgerald Upgrades Aurora Cannabis to Overweight, Raises Price Target to $5.85

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.